Brian P. McKeon, Director at DENTSPLY SIRONA Inc. (XRAY), bought 10,000 shares at $10.12 ($101K) on 2026-06-12, disclosed to the SEC on 2026-06-15.
Director Brian P. McKeon purchased $101,200 worth of shares at $10.12, marking the largest insider purchase in the company's history and signaling confidence in the stock's recovery potential. The trade comes as the stock trades near a 52-week low, potentially offering an attractive entry point for contrarian investors.
XRAY is currently trading at $10.13, down 1.22% over the last 5 days and 35.19% over the past year, placing it 40.73% below its 52-week high of $17.09 and 7.71% above its 52-week low of $9.41.
1) Q2 2026 earnings on August 6, 2026, where the company beat earnings estimates by 44.44% and revenue estimates by 1.60%. 2) The company reaffirmed full-year net sales guidance of $3.55 billion at the midpoint on August 7, 2026. 3) Three other insiders bought shares in the last 30 days, indicating a growing cluster of insider support.
1) The stock fell 6.8% on August 11, 2026, following the Q2 earnings release, as the weak full-year revenue forecast overshadowed the earnings beat. 2) Revenue declined 4.1% year-over-year in Q2 2026, driven by lower sales volumes in key product segments and regions, including the Americas and EMEA.
Nothing distinguishes this filing.
| Filing → |
| IDXX | SELL | 2021-11-12 | $25.0M | — | Filing → |
| IDXX | SELL | 2021-11-10 | $19.0M | — | Filing → |
| ALKS | BUY | 2021-08-04 | $264K | — | Filing → |